These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32157015)

  • 81. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
    Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
    Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.
    Pietrasz D; Marthey L; Wagner M; Blanc JF; Laurent C; Turrini O; Raoul JL; Terrebonne E; Hentic O; Trouilloud I; Coriat R; Regenet N; Innominato P; Taieb J; Cunha AS; Bachet JB
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1196-205. PubMed ID: 26271395
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
    Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report.
    Kawasaki H; Hoshikawa M; Kyoden Y; Iijima T; Kojima H; Yamamoto J
    Int J Surg Case Rep; 2022 Mar; 92():106818. PubMed ID: 35158234
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node Metastases.
    Tsujie M; Fumita S; Wakasa T; Mizuno S; Ishikawa H; Kitani K; Satoi S; Okada K; Inoue K; Fukuda S; Manabe H; Ichimura N; Ueda S; Tamura T; Kawasaki T; Yukawa M; Ohta Y; Inoue M
    Int J Surg Case Rep; 2020; 72():471-476. PubMed ID: 32698268
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Laparoscopic radical distal pancreatosplenectomy with celiac axis excision following neoadjuvant chemotherapy for locally advanced pancreatic cancer.
    Kim YS; Kim JS; Kim SH; Hwang HK; Lee WJ; Kang CM
    Ann Hepatobiliary Pancreat Surg; 2022 Feb; 26(1):118-123. PubMed ID: 34907094
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [A case of R0 resection in conversion surgery after duodenal stent placement for locally advanced unresectable pancreatic cancer with duodenal stenosis].
    Iwai Y; Fujita Y; Takamoto T; Fukuda T; Imamura S; Tsunoda Y; Nagakubo S; Morohoshi Y; Koike Y; Komatsu H
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):407-414. PubMed ID: 38735749
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Splenic artery pseudoaneurysm following chemotherapy in a patient with pancreatic cancer: a case report.
    Furukawa K; Shiba H; Shirai Y; Nagata Y; Saruta M; Yanaga K
    Clin J Gastroenterol; 2020 Oct; 13(5):969-972. PubMed ID: 32468500
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy.
    Zhang B; Tang K; Dong X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):578-582. PubMed ID: 37899397
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [A Case of Non-Resectable Pancreatic Cancer with Multiple Hepatic Metastases Treated with FOLFIRINOX Therapy and Conversion Surgery].
    Akaishi T; Ishido K; Kimura N; Nagase H; Odagiri T; Fujita H; Chen Y; Saito K; Takahata T; Sato A; Hakamada K
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2551-2553. PubMed ID: 32156995
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Conversion pancreaticoduodenectomy with dual arterial reconstructions for locally advanced pancreatic cancer: Case report and literature review.
    Kimura Y; Imamura M; Itoh T; Yotsuyanagi T; Kawaharada N; Takemasa I
    Int J Surg Case Rep; 2021 Mar; 80():105692. PubMed ID: 33639500
    [TBL] [Abstract][Full Text] [Related]  

  • 93. FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.
    Luu AM; Herzog T; Hoehn P; Reinacher-Schick A; Munding J; Uhl W; Braumann C
    J Gastrointest Oncol; 2018 Apr; 9(2):E9-E12. PubMed ID: 29755782
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [A Case Report of Long Survival in Pancreatic Cancer with Superior Mesenteric Arterial Invasion Following Multimodal Therapy].
    Morimoto O; Eguchi S; Hokkoku D; Wada R; Ikeshima R; Wada N; Munakata K; Takiuchi D; Azama T; Okura E; Akamaru Y; Ota H; Kitada M; Shibata K; Ohashi H
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2342-2344. PubMed ID: 32156925
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Multidisciplinary Therapy for Unresectable Pancreatic Cancer].
    Mashiko T; Nakano A; Masuoka Y; Yamamoto S; Ozawa S; Nakagohri T
    Gan To Kagaku Ryoho; 2020 Sep; 47(9):1331-1335. PubMed ID: 33130694
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Complete response of locally advanced left-sided pancreatic cancer after modified FOLFIRINOX chemotherapy followed by conversion surgery: A case report.
    Kim SJ; Park JY; Hwang HS; Kang CM
    Ann Hepatobiliary Pancreat Surg; 2021 Aug; 25(3):390-394. PubMed ID: 34402441
    [TBL] [Abstract][Full Text] [Related]  

  • 97. "Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022.
    Oba A; Del Chiaro M; Fujii T; Okano K; Stoop TF; Wu YHA; Maekawa A; Yoshida Y; Hashimoto D; Sugawara T; Inoue Y; Tanabe M; Sho M; Sasaki T; Takahashi Y; Matsumoto I; Sasahira N; Nagakawa Y; Satoi S; Schulick RD; Yoon YS; He J; Jang JY; Wolfgang CL; Hackert T; Besselink MG; Takaori K; Takeyama Y
    Pancreatology; 2023 Sep; 23(6):712-720. PubMed ID: 37336669
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture].
    Fujiwara Y; Matsui H; Tokumitsu Y; Shindo Y; Suto R; Kato T; Kawaoka T; Ueno T; Tanabe M; Harada E; Kaino S; Ito K; Hamano K; Sakaida I; Nagano H
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2431-2433. PubMed ID: 32156955
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pathological complete response in a patient with locally advanced pancreatic adenocarcinoma treated with neoadjuvant gemcitabine and S-1: a case report and literature review.
    Hua S; Gao J; Xu Q; Hong X; Wu W
    Gland Surg; 2022 Feb; 11(2):494-503. PubMed ID: 35284319
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [A Case of Pancreatic Body Cancer with Peritoneal Dissemination Followed Up for 15 Months without Recurrence].
    Kanamaru K; Okazaki T; Tanimoto N; Tanaka S; Iwabuchi S; Owada Y; Hosono M; Kawasaki K; Nakashima T
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2248-2250. PubMed ID: 33468923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.